| e1 |
Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysisSignificance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis
Kyu Hye Choi, Sea-Won Lee, Mina Yu, Songmi Jeong, Jeong Won Lee, Jong Hoon LeeKyu Hye Choi, Sea-Won Lee, Mina Yu, Songmi Jeong, Jeong Won Lee, Jong Hoon Lee
KMSID: 1109475 J Gynecol Oncol. 2019;30(1):e1. Published online 2018 August 30 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e1 |
|
| e2 |
Factors influencing decision-making around opportunistic salpingectomy: a nationwide surveyFactors influencing decision-making around opportunistic salpingectomy: a nationwide survey
Miranda P. Steenbeek, Laura A.M. van Lieshout, Johanna W.M. Aarts, Jurgen M.J. Piek, Sjors F.P.J. Coppus, Leon F.A.G. Massuger, Rosella P.M.G. Hermens, Joanne A. de HulluMiranda P. Steenbeek, Laura A.M. van Lieshout, Johanna W.M. Aarts, Jurgen M.J. Piek, Sjors F.P.J. Coppus, Leon F.A.G. Massuger, Rosella P.M.G. Hermens, Joanne A. de Hullu
KMSID: 1109481 J Gynecol Oncol. 2019;30(1):e2. Published online 2018 August 31 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e2 |
|
| e3 |
Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot studyIncorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
Yong Jae Lee, Jung-Yun Lee, Min-Soo Cho, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae KimYong Jae Lee, Jung-Yun Lee, Min-Soo Cho, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim
KMSID: 1109482 J Gynecol Oncol. 2019;30(1):e3. Published online 2018 September 10 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e3 |
|
| e4 |
The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancerThe detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
Giorgio Bogani, Umberto Leone Roberti Maggiore, Biagio Paolini, Antonino Diito, Fabio Martinelli, Domenica Lorusso, Francesco RaspagliesiGiorgio Bogani, Umberto Leone Roberti Maggiore, Biagio Paolini, Antonino Diito, Fabio Martinelli, Domenica Lorusso, Francesco Raspagliesi
KMSID: 1109486 J Gynecol Oncol. 2019;30(1):e4. Published online 2018 September 12 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e4 |
|
| e5 |
Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysisAssociation of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis
Qingjian Ye, Juan Cheng, Minjuan Ye, Dong Liu, Yu ZhangQingjian Ye, Juan Cheng, Minjuan Ye, Dong Liu, Yu Zhang
KMSID: 1109543 J Gynecol Oncol. 2019;30(1):e5. Published online 2018 September 10 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e5 |
|
| e6 |
The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patientsThe age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients
Violante Di Donato, Zoe Page, Carlotta Bracchi, Federica Tomao, Angela Musella, Giorgia Perniola, Pierluigi Benedetti PaniciViolante Di Donato, Zoe Page, Carlotta Bracchi, Federica Tomao, Angela Musella, Giorgia Perniola, Pierluigi Benedetti Panici
KMSID: 1109488 J Gynecol Oncol. 2019;30(1):e6. Published online 2018 October 4 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e6 |
|
| e7 |
Prognostic factors of synchronous endometrial and ovarian endometrioid carcinomaPrognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
Yutaka Yoneoka, Hiroshi Yoshida, Mitsuya Ishikawa, Hanako Shimizu, Takashi Uehara, Takashi Murakami, Tomoyasu KatoYutaka Yoneoka, Hiroshi Yoshida, Mitsuya Ishikawa, Hanako Shimizu, Takashi Uehara, Takashi Murakami, Tomoyasu Kato
KMSID: 1109489 J Gynecol Oncol. 2019;30(1):e7. Published online 2018 September 17 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e7 |
|
| e8 |
A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinomaA novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma
Kenta Takahashi, Mayu Yunokawa, Shinsuke Sasada, Yae Takehara, Naoyuki Miyasaka, Tomoyasu Kato, Kenji TamuraKenta Takahashi, Mayu Yunokawa, Shinsuke Sasada, Yae Takehara, Naoyuki Miyasaka, Tomoyasu Kato, Kenji Tamura
KMSID: 1109490 J Gynecol Oncol. 2019;30(1):e8. Published online 2018 October 2 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e8 |
|
| e9 |
Efficacy and dosimetry analysis of image-guided radioactive 125I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapyEfficacy and dosimetry analysis of image-guided radioactive 125I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy
Ang Qu, Ping Jiang, Haitao Sun, Weijuan Jiang, Yuliang Jiang, Suqing Tian, Junjie WangAng Qu, Ping Jiang, Haitao Sun, Weijuan Jiang, Yuliang Jiang, Suqing Tian, Junjie Wang
KMSID: 1109544 J Gynecol Oncol. 2019;30(1):e9. Published online 2018 October 30 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e9 |
|
| e10 |
Current state and outlook for drug repositioning anticipated in the field of ovarian cancerCurrent state and outlook for drug repositioning anticipated in the field of ovarian cancer
Yusuke Kobayashi, Kouji Banno, Haruko Kunitomi, Eiichiro Tominaga, Daisuke AokiYusuke Kobayashi, Kouji Banno, Haruko Kunitomi, Eiichiro Tominaga, Daisuke Aoki
KMSID: 1109476 J Gynecol Oncol. 2019;30(1):e10. Published online 2018 October 8 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e10 |
|
| e11 |
Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
Jihye Kim, Youjean Chang, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun ChoiJihye Kim, Youjean Chang, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
KMSID: 1109477 J Gynecol Oncol. 2019;30(1):e11. Published online 2018 October 22 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e11 |
|
| e12 |
Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinomaSerum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma
Yanying Lin, Jingyi Zhou, Linlin Cao, Qi Xu, Juan Hao, Lijun Zhao, Jianliu WangYanying Lin, Jingyi Zhou, Linlin Cao, Qi Xu, Juan Hao, Lijun Zhao, Jianliu Wang
KMSID: 1109478 J Gynecol Oncol. 2019;30(1):e12. Published online 2018 October 11 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e12 |
|
| e13 |
The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratificationThe prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification
Jun Guan, Liying Xie, Xuezhen Luo, Bingyi Yang, Hongwei Zhang, Qin Zhu, Xiaojun ChenJun Guan, Liying Xie, Xuezhen Luo, Bingyi Yang, Hongwei Zhang, Qin Zhu, Xiaojun Chen
KMSID: 1109479 J Gynecol Oncol. 2019;30(1):e13. Published online 2018 October 29 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e13 |
|
| e14 |
Peritoneal cancer index in ovarian cancerPeritoneal cancer index in ovarian cancer
Wonkyo Shin, Sang-Yoon Park, Myong Cheol LimWonkyo Shin, Sang-Yoon Park, Myong Cheol Lim
KMSID: 1109480 J Gynecol Oncol. 2019;30(1):e14. Published online 2018 October 11 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e14 |
|
| e30 |
Tailoring radicality in early cervical cancer: how far can we go?Tailoring radicality in early cervical cancer: how far can we go?
Jacobus van der Velden, Constantijne H. MomJacobus van der Velden, Constantijne H. Mom
KMSID: 1109483 J Gynecol Oncol. 2019;30(1):e30. Published online 2018 November 22 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e30 |
|
| e33 |
Opportunistic salpingectomy in the NetherlandsOpportunistic salpingectomy in the Netherlands
Karl TamussinoKarl Tamussino
KMSID: 1109484 J Gynecol Oncol. 2019;30(1):e33. Published online 2018 November 22 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e33 |
|
| e38 |
Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
Myong Cheol Lim, Young-Joo Won, Mun Jung Ko, Miseon Kim, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon KimMyong Cheol Lim, Young-Joo Won, Mun Jung Ko, Miseon Kim, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon Kim
KMSID: 1109492 J Gynecol Oncol. 2019;30(1):e38. Published online 2018 December 19 DOI: http://dx.doi.org/10.3802/jgo.2019.30.e38 |
|
